Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer

被引:4
|
作者
Zhao, Hanqing [1 ]
Huang, Ying [1 ]
Tong, Guoshun [1 ]
Wu, Wei [1 ]
Ren, Yangwu [1 ]
机构
[1] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110122, Peoples R China
基金
中国国家自然科学基金;
关键词
oxidative stress; anoikis; NSCLC; TME; immune landscape; stemness; MECHANISMS;
D O I
10.3390/ijms242216188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to identify a kind of prognostic signature based on oxidative stress- and anoikis-related genes (OARGs) for predicting the prognosis and immune landscape of NSCLC. Initially, We identified 47 differentially expressed OARGs that primarily regulate oxidative stress and epithelial cell infiltration through the PI3K-Akt pathway. Subsequently, 10 OARGs related to prognosis determined two potential clusters. A cluster was associated with a shorter survival level, lower immune infiltration, higher stemness index and tumor mutation burden. Next, The best risk score model constructed by prognostic OARGs was the Random Survival Forest model, and it included SLC2A1, LDHA and PLAU. The high-risk group was associated with cluster A and poor prognosis, with a higher tumor mutation burden, stemness index and proportion of M0-type macrophages, and a lower immune checkpoint expression level, immune function score and IPS score. The calibration curve and decision-making curve showed that the risk score combined with clinical pathological characteristics could be used to construct a nomogram for guiding the clinical treatment strategies. Finally, We found that all three hub genes were highly expressed in tumor tissues, and LDHA expression was mainly regulated by has-miR-338-3p, has-miR-330-5p and has-miR-34c-5p. Altogether, We constructed an OARG-related prognostic signature to reveal potential relationships between the signature and clinical characteristics, TME, stemness, tumor mutational burden, drug sensitivity and immune landscape in NSCLC patients.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients
    Uso, Marta
    Jantus-Lewintre, Eloisa
    Calabuig-Farinas, Silvia
    Blasco, Ana
    Garcia del Olmo, Eva
    Guijarro, Ricardo
    Martorell, Miguel
    Camps, Carlos
    Sirera, Rafael
    ONCOIMMUNOLOGY, 2017, 6 (01):
  • [22] Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
    Wang, Yi
    Lei, Yu
    Zheng, Delai
    Yang, Yanhui
    Luo, Lei
    Li, Ji
    Xie, Xiaoyang
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [23] A signature of tumor immune microenvironment genes associated with the prognosis of non-small cell lung cancer
    Li, Jia
    Li, Xin
    Zhang, Chenyue
    Zhang, Chenxing
    Wang, Haiyong
    ONCOLOGY REPORTS, 2020, 43 (03) : 795 - 806
  • [24] Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
    Zheng, Ke
    Zhang, Xiu-Xia
    Yu, Xin
    Yu, Bin
    Yang, Yi-Fei
    MEDICINE, 2024, 103 (19) : E38144
  • [25] Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy
    Luo, Pei
    Yang, Qing
    Cong, Le-Le
    Wang, Xiao-Feng
    Li, Yu-Sheng
    Zhong, Xiao-Ming
    Xie, Ru-Ting
    Jia, Cheng-You
    Yang, Hui-Qiong
    Li, Wen-Ping
    Cong, Xian-Ling
    Xia, Qing
    Fu, Da
    Zeng, Qing-Hua
    Ma, Yu-Shui
    MOLECULAR MEDICINE REPORTS, 2017, 16 (01) : 238 - 246
  • [26] Cancer Testis Antigens and Mutational Load in Relation to the Immune Landscape of Non-Small Cell Lung Cancer
    Backman, M.
    Kurppa, P.
    Djureinovic, D.
    La Fleur, L.
    Persson, J.
    Mattsson, J.
    Botling, J.
    Branden, E.
    Koyi, H.
    Ponten, F.
    Micke, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1820 - S1820
  • [27] Characterizing the Metabolic and Immune Landscape of Non-small Cell Lung Cancer Reveals Prognostic Biomarkers Through Omics Data Integration
    Wang, Fengjiao
    Zhang, Yuanfu
    Hao, Yangyang
    Li, Xuexin
    Qi, Yue
    Xin, Mengyu
    Xiao, Qifan
    Wang, Peng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [28] A Meta Analysis on Prognostic Value of Patients with Non-Small Cell Lung Cancer
    Rui, Jiang
    Li Yingping
    Gu, Lijun
    Wang, Zhiyan
    Zuo, Jing
    Zha, Lin
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2018, 8 (09) : 1875 - 1880
  • [29] Combination of tumor asphericity and an extracellular matrix-related prognostic gene signature in non-small cell lung cancer patients
    Zschaeck, Sebastian
    Klinger, Bertram
    van den Hoff, Joerg
    Cegla, Paulina
    Apostolova, Ivayla
    Kreissl, Michael C.
    Cholewinski, Witold
    Kukuk, Emily
    Strobel, Helen
    Amthauer, Holger
    Bluethgen, Nils
    Zips, Daniel
    Hofheinz, Frank
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
    Zheng, Yang
    Tang, Lili
    Liu, Ziling
    BMC CANCER, 2021, 21 (01)